Attached files
| file | filename |
|---|---|
| EX-32.1 - EX-32.1 - Adverum Biotechnologies, Inc. | advm-ex321_8.htm |
| EX-31.2 - EX-31.2 - Adverum Biotechnologies, Inc. | advm-ex312_7.htm |
| EX-31.1 - EX-31.1 - Adverum Biotechnologies, Inc. | advm-ex311_6.htm |
| 10-Q - 10-Q - Adverum Biotechnologies, Inc. | advm-10q_20180331.htm |
Exhibit 12.1
Adverum Biotechnologies, Inc.
Deficiency of earnings
March 31, 2018
|
|
|
Three Months |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Ended March 31, |
|
|
Year Ended December 31, |
|
||||||||||||||
|
|
|
2018 |
|
|
2017 |
|
|
2016 |
|
|
2015 |
|
|
2014 |
|
|||||
|
|
|
(In thousands) |
|
|||||||||||||||||
|
Fixed charges: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest expense on indebtedness |
|
$ |
7 |
|
|
$ |
27 |
|
|
$ |
25 |
|
|
$ |
14 |
|
|
$ |
0 |
|
|
Interest expense on portion of rent expense representative of interest |
|
$ |
32 |
|
|
|
126 |
|
|
|
122 |
|
|
|
92 |
|
|
|
18 |
|
|
Total fixed charges |
|
$ |
38 |
|
|
$ |
152 |
|
|
$ |
147 |
|
|
$ |
106 |
|
|
$ |
18 |
|
|
Preferred stock deemed dividend |
|
$ |
0 |
|
|
$ |
0 |
|
|
$ |
0 |
|
|
$ |
0 |
|
|
$ |
3,230 |
|
|
Total fixed charges and preferred dividend |
|
$ |
38 |
|
|
$ |
152 |
|
|
$ |
147 |
|
|
$ |
106 |
|
|
$ |
3,248 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net loss |
|
|
(17,200 |
) |
|
|
(56,147 |
) |
|
|
(114,522 |
) |
|
|
(47,453 |
) |
|
|
(25,404 |
) |
|
Fixed charges per above |
|
|
38 |
|
|
|
152 |
|
|
|
147 |
|
|
|
106 |
|
|
|
18 |
|
|
Total earnings (loss) |
|
|
(17,162 |
) |
|
|
(55,995 |
) |
|
|
(114,375 |
) |
|
|
(47,347 |
) |
|
|
(25,386 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Ratio of earnings to fixed charges |
|
N/A |
|
|
N/A |
|
|
N/A |
|
|
N/A |
|
|
N/A |
|
|||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Deficiency of earnings available to cover fixed charges |
|
|
(17,200 |
) |
|
|
(56,147 |
) |
|
|
(114,522 |
) |
|
|
(47,453 |
) |
|
|
(28,634 |
) |